arrow
A

A. Spagnoletti

Fondazione IRCCS Istituto Nazionale dei Tumori
H指数:8
被引数:495

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Adjuvant Therapy for High-Risk Stage II Cutaneous Melanoma: Insights and Future Directions

高危II期皮肤黑色素瘤的辅助治疗:见解与未来方向

Cancers
IF4.4
2026-06-010
OAAI
Mucosal Melanoma of the Head and Neck: A 45-Year Experience of a Tertiary Cancer Center

头颈部黏膜黑色素瘤:一家三级癌症中心45年的经验

Cancers
IF4.4
2026-04-210
OAAI
Decoding KRAS mutation in non-small cell lung cancer patients receiving immunotherapy: A retrospective institutional comparison and literature review

解码接受免疫治疗的非小细胞肺癌患者中的KRAS突变:一项回顾性机构比较和文献综述

2025-01-011
PRE
Tyrosine kinase inhibitors-induced erythrocytosis in thyroid cancers: A novel safety signal from a retrospective study

酪氨酸激酶抑制剂诱导的甲状腺癌红细胞增多症:一项回顾性研究中的新安全信号

2024-09-010
PRE
Digital pathology predicts PD-L1 expression in metastatic NSCLC patients treated with immunotherapy

数字病理学预测接受免疫治疗的转移性非小细胞肺癌患者的PD-L1表达

2024-09-010
PRE
APOLLO 11 Project, Consortium in Advanced Lung Cancer Patients Treated With Innovative Therapies: Integration of Real-World Data and Translational Research
2024-03-011
OAAI
Artificial intelligence for predictive biomarker discovery in immuno-oncology: a systematic review

免疫肿瘤学中预测生物标志物发现的人工智能: 系统综述

2024-01-0138
OAAI
Long-term outcomes and persistent toxicities following BRAF/MEK inhibitor therapy for advanced melanoma

BRAF/MEK抑制剂治疗晚期黑色素瘤的长期结果和持续毒性

2023-11-012
PRE
Explainable radiomics, machine and deep learning models to predict immune-checkpoint inhibitor treatment efficacy in advanced non-small cell lung cancer patients

可解释的放射组学,机器和深度学习模型,用于预测晚期非小细胞肺癌患者的免疫检查点抑制剂治疗效果

2023-10-010
OA
Real-world data to build explainable trustworthy artificial intelligence models for prediction of immunotherapy efficacy in NSCLC patients
2023-01-2311
OAAI
Bone metastases are associated with worse prognosis in patients affected by metastatic colorectal cancer treated with doublet or triplet chemotherapy plus bevacizumab: a subanalysis of the TRIBE and TRIBE2 trials
2022-12-012
OAAI
Primary tumor resection (PTR) in metastatic colorectal cancer (mCRC) patients (pts) treated with upfront chemotherapy (CT) plus bevacizumab (BEV): A pooled analysis of TRIBE and TRIBE2 studies
2022-09-010
PRE
Prognostic and Predictive Role of Body Mass Index (BMI) in Metastatic Colorectal Cancer (mCRC): A Pooled Analisys of Tribe and Tribe-2 Studies by GONO
2022-09-015
PRE
Efficacy of mRNA anti-SARS-CoV-2 vaccination and dynamics of humoral immune response in patients with solid tumors: results from the institutional registry of an Italian tertiary cancer center

实体瘤患者的mRNA anti-SARS-CoV-2疫苗接种的功效和体液免疫反应的动态: 来自意大利三级癌症中心的机构注册结果

2022-07-270
OAAI